Findings presented here rationalize studying these and other RhoA inhibitors for their efficacy in resolving lethal HPS disease in a biosafety level 4 (BSL4) Syrian hamster model (15, 24). Here, RHOA is linked to Hermansky-Pudlak syndrome.